AT3022 Uses, Dosage, Side Effects and more
AT3022, the Altea Therapeutics’s fentanyl citrate transdermal patch designed to provide safe and rapid management of moderate to severe chronic pain.
| Trade Name | AT3022 |
| Generic | AT3022 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in pain (acute or chronic).
How AT3022 works
AT3022 utilizes the Company’s proprietary PassPort™ Transdermal System, developed to deliver watersoluble small molecules, proteins, carbohydrates and oligonucleotides across the skin. AT3022 is designed to provide a safer and more efficacious alternative to the currently marketed fentanyl patches that can only deliver the highly lipid-soluble base form of fentanyl.
